Literature DB >> 26884900

Propranolol treatment of subglottic hemangiomas: a review of the literature.

Lei Wu1, Xiling Wu1, Xuefeng Xu1, Zhimin Chen1.   

Abstract

Subglottic hemangiomas (SGH), which are rare benign tumors of the airway, are potentially life-threatening conditions that may require intervention. Propranolol appears to be an effective treatment for these tumors and should therefore be a first-line treatment for SGH that require intervention. This review presents the clinical presentation and diagnosis of SGH and discusses current knowledge regarding the use of propranolol for the treatment of SGH.

Entities:  

Keywords:  Hemangiomas; child; larynx; propranolol

Year:  2015        PMID： 26884900      PMCID： PMC4723745     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN： 1940-5901


  23 in total

Review 1.  Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action.

Authors:  C H Storch; P H Hoeger
Journal:  Br J Dermatol       Date:  2010-05-08       Impact factor: 9.302

2.  Propranolol for severe hemangiomas of infancy.

Authors:  Christine Léauté-Labrèze; Eric Dumas de la Roque; Thomas Hubiche; Franck Boralevi; Jean-Benoît Thambo; Alain Taïeb
Journal:  N Engl J Med       Date:  2008-06-12       Impact factor: 91.245

Review 3.  Diagnosis of subglottic hemangioma by chest CT.

Authors:  A Chetty; E Mischler; D Gregg
Journal:  Pediatr Pulmonol       Date:  1997-06

4.  Propranolol for the treatment of airway hemangiomas: a case series and treatment algorithm.

Authors:  Mai Thy Truong; Jonathan A Perkins; Anna H Messner; Kay W Chang
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2010-07-31       Impact factor: 1.675

5.  Hyperkalemia complicating propranolol treatment of an infantile hemangioma.

Authors:  Helena Pavlakovic; Silke Kietz; Peter Lauerer; Markus Zutt; Max Lakomek
Journal:  Pediatrics       Date:  2010-11-29       Impact factor: 7.124

6.  Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma: A preliminary retrospective study of French experience.

Authors:  Nicolas Leboulanger; Pierre Fayoux; Natacha Teissier; Amanda Cox; Thierry Van Den Abbeele; Laure Carrabin; Vincent Couloigner; Richard Nicollas; Jean-Michel Triglia; Sonia Ayari; Patrick Froehlich; Emmanuel Lescanne; Rémy Marianowski; Thierry Mom; Michel Mondain; Jean-Paul Marie; Gilles Roger; Eréa-Noël Garabédian; Françoise Denoyelle
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2010-08-30       Impact factor: 1.675

Review 7.  Management of infantile hemangiomas : current and potential pharmacotherapeutic approaches.

Authors:  Brittany G Craiglow; Richard J Antaya
Journal:  Paediatr Drugs       Date:  2013-04       Impact factor: 3.022

8.  Great Ormond Street Hospital treatment guidelines for use of propranolol in infantile isolated subglottic haemangioma.

Authors:  Y Bajaj; K Kapoor; S Ifeacho; C G Jephson; D M Albert; J I Harper; B E Hartley
Journal:  J Laryngol Otol       Date:  2013-02-01       Impact factor: 1.469

Review 9.  Initiation and use of propranolol for infantile hemangioma: report of a consensus conference.

Authors:  Beth A Drolet; Peter C Frommelt; Sarah L Chamlin; Anita Haggstrom; Nancy M Bauman; Yvonne E Chiu; Robert H Chun; Maria C Garzon; Kristen E Holland; Leonardo Liberman; Susan MacLellan-Tobert; Anthony J Mancini; Denise Metry; Katherine B Puttgen; Marcia Seefeldt; Robert Sidbury; Kendra M Ward; Francine Blei; Eulalia Baselga; Laura Cassidy; David H Darrow; Shawna Joachim; Eun-Kyung M Kwon; Kari Martin; Jonathan Perkins; Dawn H Siegel; Robert J Boucek; Ilona J Frieden
Journal:  Pediatrics       Date:  2012-12-24       Impact factor: 7.124

10.  Successful treatment of isolated subglottic haemangioma with propranolol alone.

Authors:  Chris G Jephson; Francesca Manunza; Samira Syed; Nikki A Mills; John Harper; Ben E J Hartley
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2009-09-30       Impact factor: 1.675
View more
  1 in total

1.  Treatment failure with propranolol for subglottic haemangioma.

Authors:  Zhaobo Liu; Yen Huan Yeo; Conor Jackson; Keith Trimble
Journal:  BMJ Case Rep       Date:  2019-05-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.